A multicenter, double-blind, randomized, phase 3 study of doripenem versus comparator antibiotic in the treatment of complicated intra-abdominal infections
Phase of Trial: Phase III
Latest Information Update: 06 Apr 2010
At a glance
- Drugs Doripenem; Meropenem
- Indications Bacterial infections; Intra-abdominal infections
- Focus Registrational; Therapeutic Use
- Sponsors Janssen Research & Development
- 06 Apr 2010 Actual number of patients (478) added as reported by ClinicalTrials.gov record.
- 06 Jun 2008 EMEA approved intital MAA for the treatment of adults with complicated intra-abdominal infections.
- 11 Dec 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History